https://european-biotechnology.net/wp-content/uploads/2026/01/Dany-Kurniawan-on-Pexels-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-28 12:53:082026-01-28 12:53:08Sensorion raised €60M backed by €20M from Sanofi to advance gene therapies for hearing loss
https://european-biotechnology.net/wp-content/uploads/2026/01/cute-little-girl-pointing-her-ear-white-background-closeup-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-28 12:00:282026-01-28 12:00:28Dresden biotech Seamless lands up to $1.1B Eli Lilly deal for gene therapy hearing loss
https://european-biotechnology.net/wp-content/uploads/2026/01/Rudolfs-Klintsons-1030x773-1.jpg7731030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-27 16:40:042026-01-27 16:40:04UK and US venture firm Epidarex Capital announced first close fund of $145M to build life sciences start-ups
https://european-biotechnology.net/wp-content/uploads/2026/01/sangharsh-lohakare-8o_LkMpo8ug-unsplash-1030x579-1.jpg5791030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-27 15:52:432026-01-27 15:52:43After decades in biotech, Gimv draws a line under new life sciences deals
https://european-biotechnology.net/wp-content/uploads/2026/01/Adv_11_22_ABA_Austria.png540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-27 14:09:582026-01-27 14:09:58For €170 million: Vienna gives AI and life sciences a new home
https://european-biotechnology.net/wp-content/uploads/2026/01/Genmab-US-Office-1-Andrei-Jackamets-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-27 05:05:062026-01-27 05:05:06Genmab pauses enrollment in early ADC trial acquired from ProfoundBio
https://european-biotechnology.net/wp-content/uploads/2026/01/pexels-abdoo-35143804-1030x687-1.jpg6871030Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2026-01-23 15:23:072026-01-23 15:23:07London-based Ellipses licenses another oncologic asset from Chinese pharma
